HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lys184 deletion in troponin I impairs relaxation kinetics and induces hypercontractility in murine cardiac myofibrils.

AbstractAIMS:
To understand the functional consequences of the Lys184 deletion in murine cardiac troponin I (mcTnI(DeltaK184)), we have studied the primary effects of this mutation linked to familial hypertrophic cardiomyopathy (FHC) at the sarcomeric level.
METHODS AND RESULTS:
Ca(2+) sensitivity and kinetics of force development and relaxation were investigated in cardiac myofibrils from transgenic mice expressing mcTnI(DeltaK184), as a model which co-segregates with FHC. Ca(2+)-dependent conformational changes (switch-on/off) of the fluorescence-labelled human troponin complex, containing either wild-type hcTnI or mutant hcTnI(DeltaK183), were investigated in myofibrils prepared from the guinea pig left ventricle. Ca(2+) sensitivity and maximum Ca(2+)-activated and passive forces were significantly enhanced and cooperativity was reduced in mutant myofibrils. At partial Ca(2+) activation, mutant but not wild-type myofibrils displayed spontaneous oscillatory contraction of sarcomeres. Both conformational switch-off rates of the incorporated troponin complex and the myofibrillar relaxation kinetics were slowed down by the mutation. Impaired relaxation kinetics and increased force at low [Ca(2+)] were reversed by 2,3-butanedione monoxime (BDM), which traps cross-bridges in non-force-generating states.
CONCLUSION:
We conclude that these changes are not due to alterations of the intrinsic cross-bridge kinetics. The molecular mechanism of sarcomeric diastolic dysfunction in this FHC model is based on the impaired regulatory switch-off kinetics of cTnI, which induces incomplete inhibition of force-generating cross-bridges at low [Ca(2+)] and thereby slows down relaxation of sarcomeres. Ca(2+) sensitization and impairment of the relaxation of sarcomeres induced by this mutation may underlie the enhanced systolic function and diastolic dysfunction at the sarcomeric level.
AuthorsBogdan Iorga, Natascha Blaudeck, Johannes Solzin, Axel Neulen, Ina Stehle, Alfredo J Lopez Davila, Gabriele Pfitzer, Robert Stehle
JournalCardiovascular research (Cardiovasc Res) Vol. 77 Issue 4 Pg. 676-86 (Mar 01 2008) ISSN: 0008-6363 [Print] England
PMID18096573 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Troponin I
  • diacetylmonoxime
  • Diacetyl
  • Lysine
Topics
  • Animals
  • Calcium Signaling
  • Cardiomyopathy, Hypertrophic, Familial (genetics, metabolism, physiopathology)
  • Diacetyl (analogs & derivatives, pharmacology)
  • Disease Models, Animal
  • Guinea Pigs
  • Humans
  • Kinetics
  • Lysine
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Muscle Contraction (drug effects)
  • Muscle Strength
  • Myofibrils (metabolism, pathology)
  • Papillary Muscles (drug effects, metabolism, pathology, physiopathology)
  • Protein Conformation
  • Sarcomeres (metabolism)
  • Sequence Deletion
  • Troponin I (chemistry, genetics, metabolism)
  • Ventricular Dysfunction, Left (genetics, metabolism, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: